A study to assess zibotentan pharmacokinetics in participants with moderate hepatic and moderate renal impairment

Trial Identifier: D4326C00001
Sponsor:AstraZeneca
NCTID:NCT05112419
Start Date:November 2021
Primary Completion Date: December 2021
Study Completion Date: December 2021
Condition: Kidney Diseases; Liver, Pancreas & Gallbladder - Other

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

LanguageDescription
English Version
Bulgarian Translation

Trial Locations

CountryLocation
BG Sofia, BG, 1612